The major goal of the Skin Diseases Research Center at the University of Wisconsin (UWSDRC) is to make our funded research program more effective by bringing new investigators into skin disease and cutaneous biology research, both established investigators new to the field as well as new basic scientists and physician scientists who wish to pursue research in these areas. The administrative core is set up to ensure that this goal is accomplished at its best. This Core is headed by Gary S. Wood, MD who has demonstrated a sustained commitment to excellence in cutaneous biology research and possesses outstanding administrative abilities. He is assisted by an Associate Director (Hasan Mukhtar, PhD), who served in the same capacity for the Case Western Reserve University SDRC since the time it was established there in 1988 until he moved to the University of Wisconsin-Madison in 2002. The Core is comprised of the Director, Associate Director, Executive Committee, Enrichment Program Director and Leaders of the Mentoring, Pilot and Feasibility Studies, and Gender and Minority Awareness Programs, as well as two Administrators. The Administrative Core oversees the fiscal management of all functions of the UWSDRC including monitoring and maintenance of the three service cores (cell culture, experimental cutaneous pathology and evolving technology) to ensure their effective utilization on demand by all UWSDRC members. The Enrichment Program strives to expand the research base in the area of skin biology and disease by enhancing the already existing 1) Visiting Professor Program, 2) T32 funded Mentoring Program, 3) Grand Rounds and the Basic Science Journal Club, 4) the Dermatology Translational Initiatives Pilot Funding Program, and 5) Department of Dermatology Monday Morning Research Meetings where Pis and their Associates and Fellow present their work in progress and discuss ethical considerations of conducting biomedical research. In addition, the Enrichment Program will solicit, review, award, guide and monitor the progress of the Pilot and Feasibility studies funded at $200,000 annually. To ensure translation of research from the laboratory to patients, we have partnered with our UW NIH CTSA-funded Institute of Clinical and Translational Research (ICTR) to award up to $100,000 more annually for pilots focused on clinical and/or translational studies of skin disease. The core will also 1) maintain a website, 2) publish a newsletter, 3) organize an annual retreat, and 4) coordinate seminars, workshops, lectures, and one-on-one interactions with visiting distinguished scientists. The Administrative Core will be guided by its Executive Committee, the Internal Advisory Board and External Advisory Board.

Public Health Relevance

The Administrative Core will coordinate all UWSDRC activities. It will ensure that NIAMS support of the skin diseases research program at UW-Madison flourishes and fulfills all of its objectives in an efficient, cost effective and timely manner.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR066524-05
Application #
9542713
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Rank, Leslie A; Walsh, Naomi M; Lim, Fang Yun et al. (2018) Peptide-Like Nylon-3 Polymers with Activity against Phylogenetically Diverse, Intrinsically Drug-Resistant Pathogenic Fungi. mSphere 3:
Zhao, Lei; Okhovat, Jean-Phillip; Hong, Eric K et al. (2018) Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma. Neoplasia 21:82-92
Denu, Ryan A; Shabbir, Maria; Nihal, Minakshi et al. (2018) Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma. Mol Cancer Res 16:517-527
Salva, Katrin A; Kim, Youn H; Rahbar, Ziba et al. (2018) Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma. Photochem Photobiol 94:1058-1065
Prathap, M U Anu; Rodríguez, Carlos Iván; Sadak, Omer et al. (2018) Ultrasensitive electrochemical immunoassay for melanoma cells using mesoporous polyaniline. Chem Commun (Camb) 54:710-714
Syed, Deeba N; Aljohani, Ahmed; Waseem, Durdana et al. (2018) Ousting RAGE in melanoma: A viable therapeutic target? Semin Cancer Biol 49:20-28
Wilking-Busch, Melissa J; Ndiaye, Mary A; Liu, Xiaoqi et al. (2018) RNA interference-mediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis. J Proteomics 170:99-109
Rady, Islam; Bloch, Melissa B; Chamcheu, Roxane-Cherille N et al. (2018) Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. Oxid Med Cell Longev 2018:1826170
Karrys, Amitis; Rady, Islam; Chamcheu, Roxane-Cherille N et al. (2018) Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis. Nutrients 10:
Rodríguez, Carlos I; Castro-Pérez, Edgardo; Longley, B Jack et al. (2018) Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression. Cancer Lett 414:268-277

Showing the most recent 10 out of 31 publications